Twin Health
Total Raised
$198.56MTwin Health Funding, Twin Health Valuation & Twin Health Revenue
6 Fundings
Twin Health's latest funding round was a Series C - II for $14.81M on December 17, 2021.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
12/17/2021 | Series C - II | $14.81M | 1 | |||
10/6/2021 | Series C | |||||
10/27/2020 | Series B | |||||
6/30/2020 | Series A | |||||
4/15/2020 | Loan |
Date | 12/17/2021 | 10/6/2021 | 10/27/2020 | 6/30/2020 | 4/15/2020 |
|---|---|---|---|---|---|
Round | Series C - II | Series C | Series B | Series A | Loan |
Amount | $14.81M | ||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 1 |
You May Also Like
Wellthy Therapeutics is a digital therapeutics (DTx) company that enables individuals to manage and prevent their chronic health conditions. The clinically-validated products are used by pharma and medical device partners as a companion therapy to improve real-world patient outcomes. The DTx suite works as an active digital ingredient beyond the drug, the device, and the insurance policy to improve patient outcomes. The company's active therapeutic areas are in Diabetes, Cardiology, Nephrology, Respiratory, with upcoming therapeutics in development in Women’s Health and Oncology.
Levels is a health and wellness company committed to advancing personalized health knowledge. Through data-driven discovery, science-backed education, and individualized insights, Levels motivates people to optimize their metabolic well-being. Levels was founded in 2019 and is based in New York, New York.
Fitterfly offers scientific and personalized digital therapeutics (DTx) programs for diabetes, pregnancy, PCOS, and weight loss. The company uses smart technology and science to help people with diabetes, pregnancy, PCOS, obesity, and many more conditions achieve their health goals. The diabetes management program, Diabefly, has proven to reduce HbA1c in 85% of customers.
Lori provides a mobile platform to manage cholesterol issues, hypertension, and diabetes.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.